Collecting data

Li, Tianjing; Higgins, Julian P T; Deeks, Jonathan J

doi:10.1002/9781119536604.ch5

Cited by 153 publications

(139 citation statements)

References 60 publications

Supporting

Mentioning

139

Contrasting

Order By: Relevance

“…Citing articles and references in the studies assessed for eligibility in the full-text phase were reviewed to identify any additional eligible records. Data were extracted from all eligible studies into a standardized Excel sheet designed on the basis of recommendations from the Cochrane Collaboration[ 16 ] (for details on data extraction, see ).…”

Section: Methodsmentioning

confidence: 99%

Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review

Juhász¹,

Ocskay²,

Kiss³

et al. 2020

WJG

View full text Add to dashboard Cite

BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, mostly causing respiratory symptoms, is also known to affect the gastrointestinal tract. Several case reports hypothesize that SARS-CoV-2 could be an etiological factor in acute pancreatitis (AP). AIM To assess all the available evidence in the literature relating to coronavirus disease 2019 (COVID-19) and AP. METHODS We performed a systematic review of the available literature on the topic. The systematic search was conducted on 15 May 2020 on MEDLINE, EMBASE, CENTRAL, Web of Science and Scopus with a search key using the terms “amylase,” “lipase,” “pancr*,” “COVID-19” and synonyms. Due to the low quality and poor comparability of the studies, a meta-analysis was not performed. RESULTS Six case reports and two retrospective cohorts were included, containing data on eleven COVID-19 patients with AP. Five patients had AP according to the Atlanta classification. Other publications did not provide sufficient information on the diagnostic criteria. Most cases were considered SARS-CoV-2-induced, while several established etiological factors were not investigated. We were able to identify other possible causes in most of them. CONCLUSION We strongly highlight the need for adherence to the guidelines during a diagnostic and etiological workup, which could alter therapy.

show abstract

Section: Methodsmentioning

confidence: 99%

Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review

Juhász¹,

Ocskay²,

Kiss³

et al. 2020

WJG

View full text Add to dashboard Cite

show abstract

“…A data collection form and tool will be created and pilot tested in consideration of the recommendations in chapter 5.3 and 5.4 of the Cochrane Handbook. 39 Two review team members will extract data independently; discrepancies will be resolved through discussion, including the third review team member where necessary. In the case of missing data or unclear study information, we will again consult previous review articles or—if an accurate email address is available—ask the study authors to provide the relevant information on intervention characteristics and outcome data.…”

Section: Methods and Analysismentioning

confidence: 99%

Network meta-analysis on the comparative efficacy of family interventions for psychotic disorders: a protocol

Laskowski

Lincoln

2021

BMJ Open

View full text Add to dashboard Cite

IntroductionFamily interventions are effective and are strongly recommended for psychotic disorders. However, there is a variety of intervention types, and their differential efficacy is widely unclear. The aim of the planned network meta-analysis (NMA) is to compare the efficacy of family interventions that differ in content (eg, psychoeducation, mutual support, skills training) and format (eg, number of sessions, inclusion of patients, form of delivery).Methods and analysisWe will include randomised controlled trials comparing psychosocial interventions directed at the adult relatives, friends or non-professional carers of people with a diagnosis of a psychotic disorder (schizophrenia spectrum) to any kind of control condition. The main outcomes will be global clinical state for the patients and coping with psychosis as well as attitudes towards psychosis for the relatives. Additional outcomes will be severity of symptoms, functioning, burden and compliance/drop-out. We conducted a comprehensive search of Cochrane Central Register of Controlled Trials, MEDLINE(R), PsycINFO, Cumulative Index to Nursing & Allied Health Literature (8 August 2019) and reference lists of review articles. Full-text assessment of eligibility, data extraction and risk-of-bias assessment will be done by two independent reviewers. An NMA will be conducted for any of the planned outcomes and intervention characteristics for which sufficient and appropriate data are available. The analyses will make use of a random effects model within a frequentist framework. Estimates for all pairwise treatment effects will be obtained using standardised mean differences for continuous outcomes and risk ratios for dichotomous outcomes. Interventions will be ranked according to their relative efficacy. We will address the assumption of transitivity, heterogeneity and inconsistency using theoretical and statistical approaches. The possibility of publication bias and the strength of evidence will also be examined.Ethics and disseminationThere are no ethical concerns. Results will be published in peer-reviewed journals and presented at practitioners’ conferences.PROSPERO registration numberCRD42020148728.

show abstract

“…Agreement by reviewers at first and second review will be assessed by kappa statistic using previously reported levels of 0.40–0.59 fair, 0.60–0.74 good and 0.75 or more as excellent agreement. 74 …”

Section: Methodsmentioning

confidence: 99%

Practicability of lower extremity functional performance tests and their measurement properties in elite athletes: protocol for a systematic review

et al. 2020

View full text Add to dashboard Cite

IntroductionLower extremity injury (LEI) is highly prevalent and its occurrence increases the risk of future injury in athletic populations. Identifying athletes at risk of injury is the key to target injury-prevention programmes. Functional performance tests (FPT) assess an athlete’s ability to produce and accept forces during movement tasks reflective of those experienced in sport, and are used to identify deficits in physical qualities or neuromuscular control. This review aims to identify FPT which have potential to predict LEI and assess their measurement properties associated with reliability, validity, responsiveness and practicability (interpretability and feasibility).Methods/analysisThis protocol will be reported using the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocol and the COnsensus-based Standards for the selection of health Measurement INstruments Methodology. The search strategy has two stages: stage 1 will identify lower limb FPT used in athletic populations; and stage 2 will assess the measurement properties of the identified FPT. A sensitive search strategy will use MEDLINE, EMBASE, CINHAL and SPORTdiscus databases; from inception to June 2020. Hand searching reference lists, key journals and grey literature will be completed. One reviewer will complete search 1 and data extraction. Two reviewers will complete the search, data extraction and risk-of-bias assessment for search 2. Evidence will be pooled or summarised by individual measurement property by each individual study and grouped by FPT. Meta-analysis using a random effects model with subgroup analysis will be performed where possible. Pooled or summarised results for each FPT in relation to each measurement property will be rated against the criteria for good measurement properties. Two reviewers will assess the overall body of evidence per measurement property per FPT using the modified Grading of Recommendations, Assessment, Development and Evaluation guidelines. This review will enable clinicians to make an informed choice when selecting FPT.Ethics and disseminationNo ethical approval is required for this review and the results will be disseminated through peer-reviewed publications and submitted for conference presentation.PROSPERO registration numberCRD42020188932.

show abstract

Collecting data

Cited by 153 publications

References 60 publications

Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review

Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review

Network meta-analysis on the comparative efficacy of family interventions for psychotic disorders: a protocol

Practicability of lower extremity functional performance tests and their measurement properties in elite athletes: protocol for a systematic review

Contact Info

Product

Resources

About